📄 3CL(pro) inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.

keywords

author 👤 Sisay, Mekonnen

year ⏰ 2020

journal 📚 Pharmacol Res

issn 🗄

volume

number

page

doi 📄 10.1016/j.phrs.2020.104779 ⤴

citedbycount 0

download 🔖 [BibTeX]